CACansel Atinkaya

Cansel Atinkaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cansel Atinkaya has a total of 122 co-authors. Here are the top co-authors by number of shared publications:

  • Elçin Ersöz Köse

    Department of Thoracic Surgery, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye

    4 shared publications
  • Gökhan Yuncu

    Department of Thoracic Surgery, Pamukkale University Faculty of Medicine, Denizli, Turkey

    4 shared publications
  • Figen Turk

    Department of Thoracic Surgery, Pamukkale University Faculty of Medicine, Denizli, Turkey

    3 shared publications
  • Gökhan Ozturk

    Department of Thoracic Surgery , Pamukkale University Faculty of Medicine , Denizli , Turkey

    3 shared publications
  • İrfan Yalçinkaya

    Department of Thoracic Surgery, Health Sciences University Istanbul Hamidiye Medical Faculty, Süreyyapaşa Chest Diseases and Thoracic Surgery Hospital, Istanbul, Türkiye

    3 shared publications
  • Akin Ozturk

    Department of Medical Oncology Outpatient Clinic, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey

    2 shared publications

Latest Publications

  • Open Access

    Comparison of prognosis between patients undergoing surgical resection and stereotactic ablative radiotherapy for early-stage lung cancer

    by Pelin Erdizci, Elçin Ersöz Köse, Mustafa Akyıl, Cansel Atinkaya Baytemir, Rashad Rzazade, Selami Volkan Baysungur

    Surgical resection is the standard curative treatment for stage I non-small cell lung cancer (NSCLC), whereas stereotactic body radiotherapy (SBRT) is an established alternative for patients who are medically inoperable or decline surgery. However, comparative long-term oncologic outcomes remain debated. This study compared outcomes of surgery and SBRT in patients with clinical stage I NSCLC. This retrospective two-center cohort study included 157 patients treated between 2010 and 2022 (93 surgery, 64 SBRT). The surgical cohort included a substantial proportion of thoracotomy procedures, reflecting routine clinical practice. Overall survival (OS), disease-free survival (DFS), local control (LC), and locoregional control (LRC) were estimated using Kaplan–Meier analysis. Multivariable Cox regression was used to adjust for baseline differences. Because histological confirmation was unavailable in a subset of SBRT patients, a sensitivity analysis restricted to histologically confirmed NSCLC cases (n = 143) was performed. Median follow-up was 57 months in the surgical group and 48 months in the SBRT group. Median OS, DFS, LC, and LRC numerically favored surgery, although no statistically significant differences were observed (p > 0.05). Five-year OS was 58% after surgery and 49% after SBRT. The SBRT cohort had a higher burden of comorbidities (93% vs. 56%). Distant metastasis occurred more frequently after SBRT (28.1% vs. 15.1%, p = 0.006). Sensitivity analysis of histologically confirmed cases yielded results consistent with the primary analysis. Surgical resection and SBRT demonstrated comparable oncologic outcomes in this real-world cohort of stage I NSCLC. SBRT remains an effective option for medically inoperable patients, whereas surgery offers the advantage of pathological staging in eligible individuals. Consistent findings in the histologically confirmed cohort support the robustness of these results. Prospective randomized trials are needed to further define optimal management. Not applicable.

  • Open Access

    A case developing bilateral bullae due to COVID-19 infection and operated for recurrent pneumothorax

    by Elçin Ersöz Köse, Kaan Ayberk Boyacıoğlu, Sümeyye Alparslan Beki̇r, Cansel Ati̇nkaya Baytemi̇r, İrFan Yalçınkaya

    In December 2019, a novel coronavirus (COVID-19) pneumonia emerged in Wuhan, China and has rapidly spread to multiple countries worldwide. Pulmonary parenchymal opacities are often observed during chest radiography. Pneumothorax was reported in 1% of patients in studies. In this paper, we aimed to present a patient with a history of long-term hospitalization in intensive care unit due to COVID-19 pneumonia who was operated for right recurrent pneumothorax secondary to COVID-19 after discharge.

  • Open Access

    Erken Evre Küçük Hücreli Dışı Akciğer Kanserli Hastalarda Tiyol-Disülfid Homeostazisin Prognoz Üzerine Etkisi

    by Murat Kavas, Cansel Ati̇nkaya Baytemi̇r, Murat Alişik, Akın ÖZTÜRK, Sümeyye Alparslan Beki̇r, Selma Aydoğan Eroğlu, Elçin Ersöz Köse, İrfan Yalçinkaya, Özcan Erel

    Objective: Lung cancer has a poor prognosis. Thiol groups with high antioxidant capacity are converted to disulfide bonds through biochemical reactions that neutralize different oxidant compounds. The thiol-disulfide (SH-SS) homeostasis has significant effects on cell mechanisms, transcription, and apoptosis. Here we present the prognostic role of dynamic SH-SS homeostasis in patients operated for NSCLC. Materials and Methods: Patients operating for early-stage NSCLC were prospectively analyzed. SH-SS homeostasis tests were measured using the automated spectrophotometric method. Results: This study enrolled 138 subjects, including 77 patients and 61 healthy controls. Native thiol and total thiol levels were significantly lower in the patient group. The disulfide-to-native thiol ratio, which is an indicator of oxidative stress in SH-SS homeostasis, also reached a level of statistical significance in the patient group (p<0.001). According to the cut-off values (305 and 326.3), the median overall survival rate was significantly shorter in patients with low native thiol and total thiol levels (p<0.001). Conclusions: This study demonstrated decreased native thiol and total thiol levels as well as decreased disulfide levels and SS/SH ratio in early-stage NSCLC. Impaired SH-SS homeostasis may contribute to lung cancer pathogenesis and poor prognosis because of enhanced oxidative stress.


  • Open Access

    Malignant Mesothelioma Presenting with Spontaneous Pneumothorax

    by Ayşe ULUSOY, Elçin Ersöz Köse, Alper Süer, Rıza Serdar Evman, Cansel Ati̇nkaya Baytemi̇r, İrfan Yalçinkaya

    Malign plevral mezotelyoma (MPM), genellikle asbest maruziyeti ile oluşan, lokal, invaziv karakterli bir tümördür. MPM çoğunlukla asemptomatik seyretmesine rağmen tümörün boyutu ve komplikasyonları nedeniyle nefes darlığı, göğüs ağrısı gibi semptomlar verebilmektedir. Genellikle plevral efüzyon ile tespit edilen MPM, nadiren spontan pnömotoraks sonrası tanı almaktadır. MPM'nin tedavisinde tümör cerrahi olarak rezeke edilebilecekse plevral dekortikasyon, plörektomi veya ekstraplevral pnömonektomi gibi cerrahi teknikler bulunmaktadır. Cerrahiye uygun olmayan hastalar içinse kemoterapi uygun bir seçenektir. Yazımızda 69 yaşında bilinen bir hastalığı olmayan spontan pnömotoraks ile kliniğimize başvuran hastada total plörektomi materyalinden MPM tanısı alan olgu sunulacaktır. Bu çalışmada, malign mezotelyomanın nadiren de olsa pnömotoraks tablosuyla görülebileceği gösterilmiştir.

  • Fibrin Glue and Partial Capitonnage in Giant Hydatid Cyst in a Pediatric Patient

    by Ayşe Ulusoy, Cansel Atinkaya Baytemir, Murat Kavas, Sümeyye Alparslan Bekir, Elçin Ersöz, Sipan Bilek, İrFan Yalçınkaya


  • Rare Lung Tumors: Alveolar Adenoma-Four Case Reports

    by Murat Kavas, Akin Ozturk, Onur Derdiyok, Cansel Atinkaya, Senol Urek, Abdurrahman Yilmaz, Ayse Ersev, Irfan Yalcinkaya

    Turkthoracj, Turkish Thoracic Journal


  • Open Access

    Nonintubated surgical biopsy of undetermined interstitial lung disease: a multicentre outcome analysis

    by Eugenio Pompeo, Paola Rogliani, Cansel Atinkaya, Francesco Guerrera, Enrico Ruffini, Marco Antonio Iñiguez-Garcia, Michael Peer, Luca Voltolini, Claudio Caviezel, Walter Weder, et al.

    Nonintubated surgical biopsy (NISB) of interstitial lung disease (ILD) has shown promise in unicentre reports as a reliable method to achieve pathological diagnosis with low morbidity. The aim of this study was to investigate for the first time early outcomes of NISB of ILD using a multicentre retrospective analysis. Seven European and extra-European institutions participated in the study. Overall, 112 procedures were included. The mean age was 60 ± 12 years (65 men and 47 women). Preoperative total lung capacity and diffusion capacity of carbon monoxide were 74 ± 16% predicted and 57 ± 18% predicted, respectively. Forty-five patients had 1 or more associated comorbidities. NISB of ILD were performed under spontaneous ventilation by intercostal block (n = 84) or epidural anaesthesia (n = 28) with (n = 58) or without (n = 54) sedation and by thoracoscopic surgery (n = 88) or minithoracotomy (n = 24). Mean anaesthesia time, operative time and global time spent in the operating room were 31 ± 31 min, 29 ± 15 min and 89 ± 156 min, respectively. Feasibility was scored as excellent, good, satisfactory or unsatisfactory requiring conversion to general anaesthesia with intubation in 92, 12, 2 and 6 instances, respectively. There were no deaths. Morbidity was 7.1% and included prolonged air leaks in 4 patients and pneumonia, atelectasis, anaemia and gastric bleeding in 1 patient each. A precise pathological diagnosis was achieved in 108 patients (96%). The mean hospital stay was 2.5 ± 2.7 days. Comparisons of results achieved in the largest single-centre series (group A, 60 patients operated on) versus those resulting from the sum of the patients operated on in the other centres (group B, 52 patients operated on) showed no differences in feasibility (P = 0.10) and morbidity (P = 0.10) whereas hospital stay was shorter in group A (1.3 ± 0.5 days vs 3.9 ± 3.4 days, P < 0.001). Results of this multicentre study confirm the satisfactory feasibility of NISB of ILD in 82% of patients with no deaths and a low morbidity rate. Intergroup comparisons indicated that the hospital stay was shorter in group A whereas there were no differences in feasibility and morbidity rates.


  • The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma

    by David Rice, Kari Chansky, Anna Nowak, Harvey Pass, Hedy Kindler, Lynn Shemanski, Isabelle Opitz, Sergi Call, Seiki Hasegawa, Kemp Kernstine, et al.


  • Venous hemangioma of the anterior mediastinum

    by Adnan Yilmaz, Murat Kavas, Ayşe Ersev, Gulbanu Horzum Ekinci, Osman Haciomeroglu, Cansel Atinkaya, Esen Akkaya

    Mediastinal hemangiomas are rare tumors, with an incidence of 0.5% or less. We herein present a case of venous hemangioma in the anterior mediastinum. A 61‐year‐old man was admitted to our hospital complaining of dyspnea. Computed tomography scan of the thorax showed a 2.5 × 3.2 × 2 cm mass in the anterior mediastinum. Using a median sternotomy approach, the tumor was completely removed. Pathological examination confirmed a venous hemangioma.


  • Open Access

    Comparison of only T3 and T3-T4 sympathectomy for axillary hyperhidrosis regarding treatment effect and compensatory sweating

    by Gökhan Yuncu, Figen Turk, Gökhan Ozturk, Cansel Atinkaya

    Patients diagnosed with axillary hyperhidrosis can face psychosocial issues that can ultimately hinder their quality of life both privately and socially. The routine treatment for axillary hyperhidrosis is T3–T4 sympathectomy, but compensatory sweating is a serious side effect that is commonly seen with this approach. This study was designed to evaluate whether a T3 sympathectomy was effective for the treatment of axillary hyperhidrosis and whether this treatment led to less compensatory sweating than T3–T4 sympathectomies among our 60-patient population. One hundred and twenty endoscopic thoracic sympathectomies were performed on 60 patients who had axillary hyperhidrosis. The sympathectomies were accomplished by means of a single-lumen endotracheal tube and a single port. The axillary hyperhidrosis patients were randomly divided into two groups with 17 patients in Group 1 undergoing T3–T4 sympathectomies and 43 in Group 2 undergoing only T3 sympathectomies. We analysed the data associated with the resolution of axillary hyperhidrosis, the degree of patient satisfaction with the surgical outcome and the quality of life in parallel with compensatory sweating after the procedure as reported by the patient and confirmed by the examiner. Moreover, the results were compared statistically. No statistically significant difference was observed between the groups based on age (P = 0.56), gender (P = 0.81), duration of the surgery (P = 0.35) or postoperative satisfaction levels (P = 0.45). However, the incidence and degree of compensatory sweating were lower in the T3 group than the T3–T4 group at the 1-year follow-up (P = 0.008). T3 sympathectomy was as effective as T3–T4 sympathectomy for the treatment of axillary hyperhidrosis based on the patients’ reported postoperative satisfaction, and the T3 group demonstrated lower compensatory sweating at the 1-year follow-up.